- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT00457301
Using Health-related Quality of Life (HRQL) in Routine Clinical Care
An Assessment of the Effects of the Use of Measures of Health-related Quality of Life in Routine Clinical Care:an Application to Lung Transplantation.
The objective of this study is to assess the effects of using HRQL measures in the clinical care of pre- and post-lung transplant patients.
The hypotheses are that the inclusion of HRQL measures, the Health Utilities Index System Mark 2(HUI2) and Mark 3 (HUI3), in routine clinical care of pre- and post-lung transplant patients, will: 1) improve patient-clinician communication;2) affect patient management; 3) improve patients' HRQL.
Studienübersicht
Status
Intervention / Behandlung
Detaillierte Beschreibung
Recently there has been increasing interest in the use of health-related quality of life (HRQL) measures in routine clinical practice. Traditionally, patient care has been based on laboratory results, medical history, and signs and symptoms diagnosed by clinicians. The inclusion of HRQL measures in routine practice may provide important and often otherwise missing information, revealing the impact of the disease or its treatment on the patient's physical, emotional and social well-being, and may assist in patient management. HRQL assessments may assist in changing the medical paradigm from a disease-centered approach to a patient-centered one.
Several studies in mental health and oncology discuss the application of HRQL measures in clinical practice. Taenzer et al (2000) and Detmar et al. (2002) provide evidence that using HRQL measures improves patient-clinician communication. Velikova et al (2004) detected impacts on communication and the emotional well-being of patients.
Using a framework based on these previous studies and the methods for the health technology assessment of diagnostic technologies (Guyatt et al. 1986), we will assess the effects of including HRQL assessments in the routine clinical care of patients undergoing solid organ transplantation (lung).
We expect that the routine use of HRQL measures in clinical practice will affect patient-clinician communication, patient management, and patient outcome.
Lung transplantation trades a fatal disease (end-stage pulmonary disease) for a chance at prolonged survival and improved quality of life, albeit with immunosuppression. In this context, generic preference-based measures such as HUI2 and HUI3 are preferred to specific measures, because they measure a broader range of health dimensions, including pain, ambulation and emotional issues that are expected to be relevant. Preference-based measures provide scores on the conventional 0.00 (dead) to 1.00 (perfect health) scale that allows for the integration of morbidity and mortality effects and calculation of quality adjusted life years (QALYs) and health-adjusted life expectancy (HALE).
Studientyp
Einschreibung (Tatsächlich)
Kontakte und Standorte
Studienorte
-
-
Alberta
-
Edmonton, Alberta, Kanada
- University of Alberta Hospital
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- pre-lung transplant:subjects who are included on the waiting list and are being seen at the out-patient clinic
- post-lung transplant subjects.
Exclusion Criteria:
- younger than 18 years of age
- diagnosed as being cognitively impaired
- unable to complete questionnaires in English
Studienplan
Wie ist die Studie aufgebaut?
Kohorten und Interventionen
Gruppe / Kohorte |
Intervention / Behandlung |
---|---|
Kontrolle
|
Patients completed the HUI2 and HUI3 before the encounter with the clinician, the result was graphically represented in the HUI score card.
Clinicians used the HUI score card as an extra tool to help them in the management of the patients
Andere Namen:
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
Communication Score
Zeitfenster: Baseline and end of study (6 months)
|
Each clinician-patient encounter was audio tape-recorded.
The content of the tape-recordings was examined and results recorded on the communication form by three blinded raters.
This form tallies the number of issues discussed.
The number of issues is summed to produce a communication score.
The issues discussed included health attributes included in the HUI2 and HUI3: ambulation, self-care, anxiety, depression, cognitive problems, pain (type and frequency), vision, hearing speech and dexterity problems.
|
Baseline and end of study (6 months)
|
Management Composite
Zeitfenster: At baseline and end of study (6 months)
|
Changes in clinical management were recorded in the chart review form.
The number of referrals to other healthcare providers, tests ordered (X-rays, blood test, bronchoscopies) and changes in medication (reduction or increase dosage, addition or discontinuation) were summed to produce the management composite.
|
At baseline and end of study (6 months)
|
EuroQol, EQ-5D.
Zeitfenster: At baseline and end of study (6 months).
|
Generic preference-based measure.
EQ-5D consists of two sections: a 100-point visual analog scale (VAS) and a descriptive system that contains five attributes (mobility, self-care, usual activities, pain or discomfort, and anxiety or depression) with three levels per attribute ("no problem", "some problems" and "extreme problems").Using the US scoring function EQ-5D index scores range from -0.11 (all-worst health state, worse than dead), to 0.00 (dead) to 1.00 (perfect health).
The EQ-5D is easy to complete, valid and reliable.
|
At baseline and end of study (6 months).
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
The Hospital Anxiety and Depression Scale,HADS. Completed at Baseline and End of the Study.
Zeitfenster: Baseline and end of study (6 months)
|
HADS is a self-complete mental health measure.
The scale consists of 14 items, seven of which assess anxiety and seven which assess depression.
Each item is on a four point scale and the scores are added to give a total ranging from 0 to 21 for anxiety and 0 to 21 for depression.
Higher scores indicate more severe anxiety or depression.
A cut-point of 8 or 9 indicates mild burden for the two scales; 11 or 12 indicates severe .
All the patients completed HADS at baseline and at the end of the study.
|
Baseline and end of study (6 months)
|
Mitarbeiter und Ermittler
Sponsor
Ermittler
- Hauptermittler: David H Feeny, PhD, Professor Economics, University of Alberta
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn
Primärer Abschluss (Tatsächlich)
Studienabschluss (Tatsächlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Schätzen)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
- Erkrankungen des Verdauungssystems
- Pathologische Prozesse
- Herz-Kreislauf-Erkrankungen
- Gefäßerkrankungen
- Erkrankungen der Atemwege
- Lungenkrankheit
- Säugling, Neugeborenes, Krankheiten
- Genetische Krankheiten, angeboren
- Erkrankungen der Bauchspeicheldrüse
- Hypertonie
- Fibrose
- Lungenerkrankungen, obstruktive
- Lungenerkrankung, chronisch obstruktiv
- Lungenfibrose
- Mukoviszidose
- Bluthochdruck, Lungen
Andere Studien-ID-Nummern
- IHE-188
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur HUI score card
-
NYU Langone HealthAbgeschlossenFrühgeborenenanämie (AOP)Vereinigte Staaten
-
Mayo ClinicBeendetGastroösophagealer Reflux | Hernie, Hiatal | Umfragen und Fragebögen | FundoplikatioVereinigte Staaten
-
University College, LondonAbgeschlossenCD19+-Malignome: Rückfall nach allogener TransplantationVereinigtes Königreich
-
Medical University InnsbruckBarmherzige Brüder Vienna; Tiroler Landeskrankenanstalten GmbH (TILAK); Tiroler... und andere MitarbeiterAbgeschlossenStreicheln | Ischämische Attacke, vorübergehend | Kosten-Nutzen-Analyse | Sekundärprävention | KrankheitsmanagementÖsterreich
-
Ottawa Hospital Research InstituteThe Hospital for Sick Children; University of Ottawa; Children's Hospital of Eastern... und andere MitarbeiterUnbekanntSimulation | Herzstillstand | Reanimation | AusbildungKanada
-
Boston Medical CenterAbgeschlossenZirrhose | AszitesVereinigte Staaten
-
CHU de ReimsBeendet
-
UCSF Benioff Children's Hospital OaklandNational Heart, Lung, and Blood Institute (NHLBI)AbgeschlossenAnämie, SichelzellenanämieVereinigte Staaten